Abingdon Health PLC

ABDX

Company Profile

  • Business description

    Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.

  • Contact

    York Biotech Campus
    Sand Hutton
    YorkYO41 1LZ
    GBR

    T: +44 1904406050

    E: [email protected]

    https://www.abingdonhealth.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2027

    Employees

    129

Stocks News & Analysis

stocks

Undervalued REIT receives offer from PE firm

Our analysts’ view on the value of the unsolicited offer.
stocks

Apple: With launch of foldable iPhone duo things look twice as nice

We’ve raised our fair value estimate of Apple stock.
stocks

What did Morningstar subscribers buy and sell during August?

Earnings season fuels trading activity.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,920.2013.800.15%
CAC 408,179.7763.010.78%
DAX 4025,568.56207.410.82%
Dow JONES (US)52,573.29509.190.98%
FTSE 10010,650.4441.520.39%
HKSE24,805.63148.84-0.60%
NASDAQ26,333.04251.310.96%
Nikkei 22564,011.341,259.61-1.93%
NZX 50 Index13,580.33130.68-0.95%
S&P 5007,656.9865.280.86%
S&P/ASX 2008,741.2023.300.27%
SSE Composite Index3,888.1146.29-1.18%

Market Movers